CIK 0001757499 · <br>Emerging growth company
Shuttle Pharmaceuticals Holdings, Inc.
Sign in to watch- Ticker
- SHPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (240) 403-4212
- Business address
- 401 PROFESSIONAL DRIVE, SUITE 260, GAITHERSBURG, MD, 20879
- Former names
- Shuttle Pharmaceuticals Holdings, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-14 | HRT FINANCIAL LP 10% owner | Sale | −82,116 | $4.48 | $368K | 0 |
| 2026-07-13 | HRT FINANCIAL LP 10% owner | Sale | −1,033 | $4.67 | $5K | 60,238 |
| 2026-07-10 | HRT FINANCIAL LP 10% owner | Purchase | +731 | $3.11 | $2K | 61,271 |
| 2026-07-09 | HRT FINANCIAL LP 10% owner | Purchase | +8,266 | $3.38 | $28K | 60,540 |
| 2026-07-08 | HRT FINANCIAL LP 10% owner | Sale | −18,531 | $3.52 | $65K | 52,274 |
| 2026-07-07 | HRT FINANCIAL LP 10% owner | Sale | −10,580 | $3.33 | $35K | 70,805 |
| 2026-07-06 | HRT FINANCIAL LP 10% owner | Sale | −9,022 | $3.51 | $32K | 81,385 |
| 2026-07-02 | HRT FINANCIAL LP 10% owner | Purchase | +7,851 | $3.54 | $28K | 90,407 |
| 2026-07-01 | HRT FINANCIAL LP 10% owner | Purchase | +3,959 | $3.30 | $13K | 82,556 |
| 2026-06-30 | HRT FINANCIAL LP 10% owner | Purchase | +6,755 | $3.23 | $22K | 78,597 |
| 2026-06-29 | HRT FINANCIAL LP 10% owner | Purchase | +25,836 | $3.44 | $89K | 71,842 |
| 2025-08-08 | Richards Steven M Director | Grant or award · Restricted Stock Unit | +29,240 | 29,240 | ||
| 2025-08-08 | Nabyt Oleh Director | Grant or award · Restricted Stock Unit | +29,240 | 29,240 | ||
| 2025-08-08 | Scorsis George Director | Grant or award · Restricted Stock Unit | +29,240 | 29,240 | ||
| 2025-08-08 | Tung Joseph Director | Grant or award · Restricted Stock Unit | +29,240 | 29,240 | ||
| 2025-08-08 | Lorber Timothy J. Chief Financial Officer | Grant or award · Restricted Stock Unit | +29,240 | 29,240 | ||
| 2025-08-08 | Lorber Timothy J. Chief Financial Officer | Grant or award · Restricted Stock Unit | +24,854 | 24,854 | ||
| 2024-05-01 | Jung Mira Chief Scientific Officer | Grant or award | −598 | $11.28 | $7K | 135,715 |
| 2024-03-08 | Vander Hoek Michael Chief Financial Officer | Grant or award | +100,000 | 103,852 | ||
| 2023-12-13 | Brown Milton Director | Sale | −2,921 | $0.46 | $1K | 1,094,610 |
Page 1 of 2 · 35 trades